Lantern Pharma
@lanternpharma
Leveraging A.I. to develop, revitalize, & rescue drugs for oncology. (Nasdaq : LTRN)
ID: 3316335803
http://www.lanternpharma.com/ 10-06-2015 00:40:56
576 Tweet
692 Takipçi
362 Takip Edilen
Lantern Pharma announced a key milestone towards development of molecular diagnostic for use in oncology clinical trials for patient selection and stratification with drug candidate LP-184. $LTRN Read the full release here bit.ly/463q1oH